about
Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunctionHow chemoproteomics can enable drug discovery and developmentSynergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models.Development of a new choroidal metastasis in resistance to crizotinib therapy in anaplastic lymphoma kinase-rearranged non-small cell lung cancerTumor control versus adverse events with targeted anticancer therapies.Crizotinib: a new treatment option for ALK-positive non-small cell lung cancer.New treatment options for lung adenocarcinoma--in view of molecular background.Analysis of driver mutations in female non-smoker Asian patients with pulmonary adenocarcinoma.Detection of ALK fusion in lung cancer using fluorescence in situ hybridization.Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinib.Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never-smoker women with pulmonary adenocarcinoma.
P2860
Q33879009-DED66B9F-DB94-41CA-B51C-F2521B4A788CQ34143272-EE8B0A1E-28B2-497E-B641-E31FE1364213Q36357215-013FEEA7-E292-45B6-BFE1-0A6856A118CFQ37647848-695A41AD-E04E-4661-BA87-4CEC6CCC4E67Q37969899-88253E91-A1B6-4071-8A63-6E1CCBEC2D52Q38079518-E99F35A1-AAB4-4B71-96C4-0EF9493BD1B7Q38168761-E64A342B-895E-499E-ACB9-FBFC0494A1EAQ50936062-16EF9C27-4932-4C35-9F4E-C78CAF038052Q51334765-157A33C6-4867-4EB3-A258-3E42E8CB1766Q52673089-7ABBCC0A-7DEA-4A98-9200-30C8B1929CBFQ54310972-FB1ED8EE-52A4-40B7-BE30-491BF3919678
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Crizotinib: an anaplastic lymphoma kinase inhibitor.
@en
Crizotinib: an anaplastic lymphoma kinase inhibitor.
@nl
type
label
Crizotinib: an anaplastic lymphoma kinase inhibitor.
@en
Crizotinib: an anaplastic lymphoma kinase inhibitor.
@nl
prefLabel
Crizotinib: an anaplastic lymphoma kinase inhibitor.
@en
Crizotinib: an anaplastic lymphoma kinase inhibitor.
@nl
P2860
P356
P1433
P1476
Crizotinib: an anaplastic lymphoma kinase inhibitor.
@en
P2093
Gerold Bepler
Shirish M Gadgeel
P2860
P304
P356
10.2217/FON.11.77
P407
P577
2011-08-01T00:00:00Z